Douglas Richard

Douglas Richard is listed in filings as Director at Aldeyra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 20, 2026, including purchase activity. Recent filings connect the profile to Aldeyra Therapeutics, Inc. (ALDX), MaxCyte, Inc. (MXCT), and Novavax, Inc. (NVAX). The current snapshot covers public activity from Jun 13, 2024 to Mar 20, 2026. Reported amounts are shown as $98.0K to $181.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.